Investment Banking and Advisory Services
RM Global is a global life science investment banking and strategic advisory firm focused in life sciences, including biopharma, biotech, medical devices, consumer/digital health, and diagnostics. Our expertise is in M&A, raising venture, growth, bridge and private equity financing, valuation advice, transaction structures, deal tactics/negotiations, corporate venture capital management, strategic consulting services. RMG provides both in-licensing and out-licensing services to facilitate technology transfer and portfolio enhancement. RM Global has a network of a diverse client base including the Americas, Europe, Israel, and Asia: Korea, Japan, and China.
Fund Management
RMGP BioPharma Fund
RMGP Biopharma Investment Fund is a Venture Capital (VC) Fund that invests in innovative, early stage biopharma assets, through its partnership with FutuRx . FutuRx is an Israel-based, globally focused drug development incubation platform, founded by Orbimed, Johnson&Johnson and Takeda.The Global BioAccess Fund
The Global BioAccess Fund invests in venture-stage companies developing novel therapeutics, and devices, primarily in North America and the EU. We fund new ventures with funds preparing for or conducting clinical trials that address serious unmet medical needs in oncology/I&I, CNS, cardiology, and rare diseases.